Atara Biotherapeutics, Inc (ATRA) Dividend History

Atara Biotherapeutics, Inc. is a biotechnology company focused on developing and commercializing innovative cellular immunotherapies for the treatment of life-threatening diseases, including cancers and rare autoimmune disorders. The company leverages allogeneic T-cell technologies to create targeted and durable treatments, aiming to improve patient outcomes in areas with significant unmet medical needs.

2380 Conejo Spectrum St, Thousand Oaks, CA, 91320
Phone: 805-623-4244
Website: https://www.atarabio.com

Dividend History

Atara Biotherapeutics, Inc currently does not pay dividends

Company News

  • Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws

    Wolf Haldenstein Adler Freeman & Herz LLP is investigating Atara Biotherapeutics, Inc. for potential securities law violations after the company received a Complete Response Letter from the FDA regarding its Ebvallo drug, leading to a clinical hold and workforce reduction.

    GlobeNewswire Inc.
  • Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline

    Biogen's (BIIB) acquisition of private biotech, HI-Bio, is set to expand its rare disease pipeline by adding the latter's lead asset, felzartamab.

    Zacks Investment Research
    Featured Companies: BIIB
  • Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

    Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD. 4D Molecular Therapeutics shares jumped 20.1% to $21.01 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Chenghe Acquisition Co. (NASDAQ: CHEA) gained 68.1% to $9.23 in pre-market trading after dipping around 46% on Friday. Tritium DCFC Limited (NASDAQ: DCFC) shares jumped 51.9% to $0.1990 in pre-market trading. Tritium DCFC said the company was the top-awarded fast charger manufacturer for the first round of the State of Tennessee’s National Electric Vehicle Infrastructure (NEVI) Formula Program. YanGuFang International Group Co., Ltd. (NASDAQ: YGF) gained 27.4% to $0.7641 in pre-market trading after falling around 19% on Friday. Magic Empire Global Limited (NASDAQ: MEGL) shares gained 21.6% to $0.9841 in pre-market trading. CalAmp Corp. (NASDAQ: CAMP) ...

    Benzinga
    Featured Companies: CAMP CCTG CVKD FDMT MEGL WORX
  • Penny Stocks To Buy Under $1? 3 For Your Holiday Watch List

    Penny stocks to buy for under $1 but are they worth the risk? The post Penny Stocks To Buy Under $1? 3 For Your Holiday Watch List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: OBLG
  • 3 Under-the-Radar Biotech Stocks to Buy in 2022

    The attraction of all three biotech stocks is their potential.

    The Motley Fool
    Featured Companies: AGIO BEAM

Related Companies

Page data last updated 07/23/2025 12:46:09 UTC